Researchers have demonstrated that metformin treatment prevents and ameliorates ARDS induced by LPS in mice, accompanied by abrogated NLRP3 inflammasome activation in macrophages, and attenuates pulmonary inflammation in COVID-19 patients (Xian et al., 2021). The gene discussed is NLRP3; the disease is COVID-19.